Results for tag: "Bepreve"

Bepreve is a topical ophthalmic solution used to treat itching associated with allergic conjunctivitis. It is a prostaglandin analog that works by inhibiting the release of histamine and other inflammatory mediators. Bepreve is the first and only FDA-approved medication for the treatment of itching associated with allergic conjunctivitis. It is available in both prescription and over-the-counter forms. The Bepreve market is composed of a variety of companies that produce and distribute the drug. These companies include Allergan, Bausch + Lomb, Merck, and Novartis. Additionally, there are a number of generic manufacturers that produce generic versions of the drug. These companies include Mylan, Teva, and Sandoz. The Bepreve market is an important part of the Optical Disorders Drugs industry. It provides a safe and effective treatment for itching associated with allergic conjunctivitis, and is widely available in both prescription and over-the-counter forms. Show Less Read more